Legal Representation
Attorney
Rhett V. Barney
USPTO Deadlines
Next Deadline
1506 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-12)
Due Date
September 12, 2029
Grace Period Ends
March 12, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jan 8, 2024 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
Dec 14, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
Dec 14, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
Dec 12, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Sep 12, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Sep 12, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Jun 27, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jun 27, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 25, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
Jun 8, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Jun 7, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jun 7, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
May 23, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 24, 2023 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
Apr 24, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 24, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 12, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Mar 12, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Mar 12, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Feb 27, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 26, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Feb 26, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 13, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Jan 13, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jan 13, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jan 13, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jan 13, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Jan 4, 2023 | RFNP | P | REFUSAL PROCESSED BY IB | Loading... |
Dec 10, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Dec 9, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Sep 29, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Sep 28, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 27, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jul 1, 2022 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
May 17, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
May 13, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 12, 2022 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
chemical preparations for pharmaceutical purposes, namely, for calibration of diagnostics tests in a form of a glycoprotein standard; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for diagnosis of oncological diseases, autoimmune diseases and neurological diseases; stem cells for medical purposes; biological tissue cultures for medical purposes; diagnostic biomarker reagents for medical purposes; medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Blood testing apparatus; testing apparatus for medical purposes for testing glycans in the nature of complex carbohydrates and sugars attached to proteins and lipids; diagnostic apparatus for medical purposes for testing glycans in the nature of complex carbohydrates and sugars attached to proteins and lipids
First Use Anywhere:
0
First Use in Commerce:
0
Class 035
Retail store services for pharmaceutical preparations, chemical preparations for pharmaceutical purposes, diagnostic preparations for medical purposes, chemical preparations for medical purposes, stem cells for medical purposes, biological tissue cultures for medical purposes, diagnostic biomarker reagents for medical purposes, blood testing apparatus, testing apparatus for medical purposes, diagnostic apparatus for medical purposes, medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases; online retail store services for pharmaceutical preparations, chemical preparations for pharmaceutical purposes, diagnostic preparations for medical purposes, chemical preparations for medical purposes, stem cells for medical purposes, biological tissue cultures for medical purposes, diagnostic biomarker reagents for medical purposes, blood testing apparatus, testing apparatus for medical purposes, diagnostic apparatus for medical purposes, medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 040
Custom manufacture of medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 041
Educational services in the nature of academies, namely, conducting seminars, workshops, lectures, practical experimental demonstrations in the field of glycomics, biomarker discovery, disease diagnostics, proteomics, life science company development; arranging and conducting of colloquiums in the field of glycomics, biomarker discovery, disease diagnostics, proteomics, life science company development; arranging and conducting of conferences in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of congresses in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of seminars in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of symposiums in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of in-person educational forums in the field of glycomics, biomarker discovery, disease diagnostics, proteomics
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Chemical analysis; chemical research; biological research; scientific laboratory services; scientific research; medical and scientific research, namely, conducting clinical validations trials for diagnostic and pharmaceutical companies; medical research
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical services; pharmacy advice, namely, pharmaceutical advice for diagnostic and pharmaceutical companies; health counselling; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
010
035
040
041
042
044